"The French Life Sciences market is at a turning point. We're seeing a favorable combination of political will, growing funding and a dynamic entrepreneurial ecosystem. However, much remains to be done to structure this market and meet growing demand. The real estate industry must transform itself to offer infrastructures adapted to the specific needs of this sector, capitalizing on the opportunities ahead." In just a few words, Nicolas Verdillon, Director of Investments France at CBRE France, gave an overview of the Life Sciences sector. His analysis is based on the consultancy's latest study, published today.
The Life Sciences sector faces a major challenge
In its latest study, CBRE France confirms that the lack of business premises is an obstacle to business development.
By Benoît Léger
Business Immo
December 16, 2024 | 1:30 P.M.
This is a machine translation. Automated translations are intended solely as a convenience and are not legally binding.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- Contacts
- Nicolas Verdillon
Managing Director, Investments Properties, CBRE France